(Q37971344)

26 August 2017

title

Gene-environment interaction in major depression and antidepressant treatment response (English)

1 reference

26 August 2017

1

1 reference

26 August 2017

Rudolf Uher

2

0 references

language of work or name

English

0 references

publication date

1 April 2012

1 reference

Current Psychiatry Reports

26 August 2017

published in

1 reference

26 August 2017

volume

14

1 reference

26 August 2017

issue

2

1 reference

26 August 2017

page(s)

129-137

1 reference

https://scigraph.springernature.com/pub.10.1007/s11920-011-0251-x

26 August 2017

exact match

0 references

cites work

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Pharmacogenetics: a new diagnostic tool in the management of antidepressive drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

The implications of gene-environment interactions in depression: will cause inform cure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Genetic epidemiology of major depression: review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Life Stressors as Risk Factors in Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Monozygotic twins discordant for major depression: a preliminary exploration of the role of environmental experiences in the aetiology and course of illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Linking molecules to mood: new insight into the biology of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

A hospital-based twin register of the heritability of DSM-IV unipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Genome-wide association study of major recurrent depression in the U.K. population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Genome-wide association study of recurrent major depressive disorder in two European case–control cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Genome-wide association study of recurrent early-onset major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Novel loci for major depression identified by genome-wide association study of Sequenced Treatment Alternatives to Relieve Depression and meta-analysis of three studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Genome-wide association for major depressive disorder: a possible role for the presynaptic protein piccolo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

A prospective investigation of major depressive disorder and comorbidity in abused and neglected children grown up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Prospectively ascertained child maltreatment and its association with DSM-IV mental disorders in young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Does the influence of childhood adversity on psychopathology persist across the lifecourse? A 45-year prospective epidemiologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Burden and consequences of child maltreatment in high-income countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Gene X environment interactions at the serotonin transporter locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

The moderation by the serotonin transporter gene of environmental adversity in the etiology of depression: 2009 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Serotonin transporter gene moderates childhood maltreatment's effects on persistent but not single-episode depression: replications and implications for resolving inconsistent results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Role of BDNF in bipolar and unipolar disorder: clinical and theoretical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Interactions between life stressors and susceptibility genes (5-HTTLPR and BDNF) on depression in Korean elders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Early adversity and 5-HTT/BDNF genes: new evidence of gene-environment interactions on depressive symptoms in a general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Stressful life events and the brain-derived neurotrophic factor gene in bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

The CREB1-BDNF-NTRK2 pathway in depression: multiple gene-cognition-environment interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Glucocorticoids as predictors of treatment response in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Interaction of childhood maltreatment with the corticotropin-releasing hormone receptor gene: effects on hypothalamic-pituitary-adrenal axis reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Interactive effects of corticotropin releasing hormone receptor 1, serotonin transporter linked polymorphic region, and child maltreatment on diurnal cortisol regulation and internalizing symptomatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Interacting effects of CRHR1 gene and stressful life events on drinking initiation and progression among 19-year-olds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Moderation of the association between childhood maltreatment and neuroticism by the corticotropin-releasing hormone receptor 1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Influence of child abuse on adult depression: moderation by the corticotropin-releasing hormone receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Protective effect of CRHR1 gene variants on the development of adult depression following childhood maltreatment: replication and extension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

A CRHR1 haplotype moderates the effect of adverse childhood experiences on lifetime risk of major depressive episode in African-American women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Polymorphisms in the FKBP5 gene region modulate recovery from psychosocial stress in healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Moderation of adult depression by a polymorphism in the FKBP5 gene and childhood physical abuse in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Interaction of FKBP5 gene variants and adverse life events in predicting depression onset: results from a 10-year prospective community study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Glucocorticoid receptor gene polymorphisms and childhood adversity are associated with depression: New evidence for a gene-environment interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Genetic variants in FKBP5 affecting response to antidepressant drug treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Variation in catechol-O-methyltransferase is associated with duloxetine response in a clinical trial for major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

The FKBP5-gene in depression and treatment response--an association study in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Brain derived neurotrophic factor gene polymorphism (Val66Met) and short-term antidepressant response in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Association of BDNF Val66Met polymorphism with both baseline HRQOL scores and improvement in HRQOL scores in Chinese major depressive patients treated with fluoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Association of a corticotropin-releasing hormone receptor 1 haplotype and antidepressant treatment response in Mexican-Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Association study of corticotropin-releasing hormone receptor1 gene polymorphisms and antidepressant response in major depressive disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Genetic predictors of response to antidepressants in the GENDEP project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Meta-analysis of FKBP5 gene polymorphisms association with treatment response in patients with mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Genetic variability at HPA axis in major depression and clinical response to antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: association with major depression and antidepressant response in Mexican-Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Prediction of treatment response by HPA-axis and glucocorticoid receptor polymorphisms in major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

A genomewide association study of citalopram response in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Genome-wide pharmacogenetics of antidepressant response in the GENDEP project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Oversulfated chondroitin sulfate plays critical roles in the neuronal migration in the cerebral cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

The ROR nuclear orphan receptor subfamily: critical regulators of multiple biological processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Genes, environment, and individual differences in responding to treatment for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Stressful life events, cognitive symptoms of depression and response to antidepressants in GENDEP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Clinical characteristics and treatment outcome of depression in patients with and without a history of emotional and physical abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Childhood emotional trauma and chronic posttraumatic stress disorder in adult outpatients with treatment-resistant depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Psychosocial and clinical predictors of symptom persistence vs remission in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Childhood neglect and abuse as predictors of antidepressant response in adult depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Pharmacogenetic studies in depression: a proposal for methodologic guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Interaction between SERTPR and stressful life events on response to antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Interaction between serotonin transporter gene variants and life events predicts response to antidepressants in the GENDEP project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

No interactions between genetic polymorphisms and stressful life events on outcome of antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Child maltreatment and adult socioeconomic well-being.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Parental maltreatment and adulthood cohabiting partnerships: a life-course study of adult chronic depression--4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Depression and the serotonin transporter 5-HTTLPR polymorphism: a review and a hypothesis concerning gene-environment interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Personality, stressful life events, and treatment response in major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-011-0251-X

Life events, vulnerability and onset of depression: some refinements

21 January 2018

1 reference

12 December 2020

Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group

1 reference

12 December 2020

Antecedent life events, social supports and response to antidepressants in depressed patients

1 reference

12 December 2020

Polymorphisms of the glucocorticoid receptor gene and major depression

1 reference

12 December 2020

Toward an integration of psychologic, social, and biologic factors in depression: Effects on outcome and course of cognitive therapy

1 reference

12 December 2020

Pharmacogenetics of antidepressant response

1 reference

12 December 2020

Impact of childhood trauma on treatment outcome in the Treatment for Adolescents with Depression Study (TADS).

1 reference

12 December 2020

Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine

1 reference

12 December 2020

Interaction of FKBP5 with childhood adversity on risk for post-traumatic stress disorder

1 reference

12 December 2020

Treatment of selective serotonin reuptake inhibitor-resistant depression in adolescents: predictors and moderators of treatment response

1 reference

12 December 2020

Genome-wide association study of major depressive disorder: new results, meta-analysis, and lessons learned

1 reference

12 December 2020

Perceived parenting pattern and response to antidepressants in patients with major depression

1 reference

12 December 2020

Adult onset of major depressive disorder in relation to early life violent victimisation: a case-control study

1 reference

12 December 2020

10.1007/S11920-011-0251-X

Identifiers

DOI

1 reference

26 August 2017

1 reference